Logo image of TALK

TALKSPACE INC (TALK) Stock Fundamental Analysis

NASDAQ:TALK - Nasdaq - US87427V1035 - Common Stock - Currency: USD

2.48  -0.04 (-1.59%)

After market: 2.5294 +0.05 (+1.99%)

Fundamental Rating

5

Taking everything into account, TALK scores 5 out of 10 in our fundamental rating. TALK was compared to 103 industry peers in the Health Care Providers & Services industry. TALK has a great financial health rating, but its profitability evaluates not so good. TALK is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

TALK had positive earnings in the past year.
In the past year TALK had a positive cash flow from operations.
In the past 5 years TALK reported 4 times negative net income.
In the past 5 years TALK reported 4 times negative operating cash flow.
TALK Yearly Net Income VS EBIT VS OCF VS FCFTALK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

TALK's Return On Assets of 2.18% is in line compared to the rest of the industry. TALK outperforms 57.28% of its industry peers.
TALK's Return On Equity of 2.59% is in line compared to the rest of the industry. TALK outperforms 55.34% of its industry peers.
Industry RankSector Rank
ROA 2.18%
ROE 2.59%
ROIC N/A
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
TALK Yearly ROA, ROE, ROICTALK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

With a Profit Margin value of 1.51%, TALK perfoms like the industry average, outperforming 58.25% of the companies in the same industry.
With a decent Gross Margin value of 44.96%, TALK is doing good in the industry, outperforming 73.79% of the companies in the same industry.
TALK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 1.51%
GM 44.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
TALK Yearly Profit, Operating, Gross MarginsTALK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

TALK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TALK has more shares outstanding
TALK has more shares outstanding than it did 5 years ago.
There is no outstanding debt for TALK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TALK Yearly Shares OutstandingTALK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
TALK Yearly Total Debt VS Total AssetsTALK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 11.63 indicates that TALK is not in any danger for bankruptcy at the moment.
TALK's Altman-Z score of 11.63 is amongst the best of the industry. TALK outperforms 94.17% of its industry peers.
TALK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.63
ROIC/WACCN/A
WACC9.11%
TALK Yearly LT Debt VS Equity VS FCFTALK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

TALK has a Current Ratio of 6.49. This indicates that TALK is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.49, TALK belongs to the best of the industry, outperforming 96.12% of the companies in the same industry.
TALK has a Quick Ratio of 6.49. This indicates that TALK is financially healthy and has no problem in meeting its short term obligations.
TALK has a better Quick ratio (6.49) than 96.12% of its industry peers.
Industry RankSector Rank
Current Ratio 6.49
Quick Ratio 6.49
TALK Yearly Current Assets VS Current LiabilitesTALK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

8

3. Growth

3.1 Past

TALK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 125.00%, which is quite impressive.
The Revenue has grown by 19.88% in the past year. This is quite good.
TALK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.48% yearly.
EPS 1Y (TTM)125%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)19.88%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%14.9%

3.2 Future

Based on estimates for the next years, TALK will show a very strong growth in Earnings Per Share. The EPS will grow by 166.23% on average per year.
TALK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.05% yearly.
EPS Next Y359%
EPS Next 2Y214.01%
EPS Next 3Y166.23%
EPS Next 5YN/A
Revenue Next Year19.29%
Revenue Next 2Y19.81%
Revenue Next 3Y20.48%
Revenue Next 5Y21.05%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
TALK Yearly Revenue VS EstimatesTALK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
TALK Yearly EPS VS EstimatesTALK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

TALK is valuated quite expensively with a Price/Earnings ratio of 124.00.
Compared to the rest of the industry, the Price/Earnings ratio of TALK is on the same level as its industry peers.
TALK's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.50.
TALK is valuated quite expensively with a Price/Forward Earnings ratio of 25.15.
TALK's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 36.44. TALK is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 124
Fwd PE 25.15
TALK Price Earnings VS Forward Price EarningsTALK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of TALK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 61.01
EV/EBITDA N/A
TALK Per share dataTALK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

TALK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TALK's earnings are expected to grow with 166.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y214.01%
EPS Next 3Y166.23%

More info and screens

0

5. Dividend

5.1 Amount

TALK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TALKSPACE INC

NASDAQ:TALK (7/18/2025, 8:14:41 PM)

After market: 2.5294 +0.05 (+1.99%)

2.48

-0.04 (-1.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-04 2025-08-04/amc
Inst Owners57.38%
Inst Owner Change0%
Ins Owners3.99%
Ins Owner Change4.14%
Market Cap414.95M
Analysts81.54
Price Target5.1 (105.65%)
Short Float %3.38%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.05%
Min Revenue beat(2)-4.06%
Max Revenue beat(2)-4.03%
Revenue beat(4)0
Avg Revenue beat(4)-2.69%
Min Revenue beat(4)-4.06%
Max Revenue beat(4)-0.55%
Revenue beat(8)4
Avg Revenue beat(8)0.6%
Revenue beat(12)6
Avg Revenue beat(12)0.36%
Revenue beat(16)8
Avg Revenue beat(16)-0.63%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-40%
EPS NY rev (1m)-10%
EPS NY rev (3m)-10%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.86%
Valuation
Industry RankSector Rank
PE 124
Fwd PE 25.15
P/S 2.13
P/FCF 61.01
P/OCF 29.95
P/B 3.66
P/tB 3.66
EV/EBITDA N/A
EPS(TTM)0.02
EY0.81%
EPS(NY)0.1
Fwd EY3.98%
FCF(TTM)0.04
FCFY1.64%
OCF(TTM)0.08
OCFY3.34%
SpS1.16
BVpS0.68
TBVpS0.68
PEG (NY)0.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.18%
ROE 2.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.51%
GM 44.96%
FCFM 3.5%
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
F-Score7
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 532.86%
Cap/Sales 3.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 231.96%
Current Ratio 6.49
Quick Ratio 6.49
Altman-Z 11.63
F-Score7
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)224%
Cap/Depr(5y)197.42%
Cap/Sales(3y)1.1%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y359%
EPS Next 2Y214.01%
EPS Next 3Y166.23%
EPS Next 5YN/A
Revenue 1Y (TTM)19.88%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%14.9%
Revenue Next Year19.29%
Revenue Next 2Y19.81%
Revenue Next 3Y20.48%
Revenue Next 5Y21.05%
EBIT growth 1Y75.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year477.85%
EBIT Next 3Y143.6%
EBIT Next 5Y109.41%
FCF growth 1Y111.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y123.11%
OCF growth 3YN/A
OCF growth 5YN/A